Sovereign backed Bioscript makes third acquisition in just over 12 months
Sovereign Capital Partners is pleased to announce that portfolio company Bioscript Group ('Bioscript’), the integrated, healthcare communications group, has acquired Meridian HealthComms.
This is the third acquisition Bioscript has made since Sovereign backed the management team in March 2021, to significantly increase its geographic footprint and extend into adjacent strategic services. Last summer the acquisitions of Fortis Pharma Consulting (‘Fortis’), a specialist medical affairs service provider, and Valid Insight, a specialist market access consultancy, were announced.
Headquartered in Macclesfield, Bioscript Group is one of the largest independent global agencies, with a strong international reputation for high-quality medical communications, regulatory writing and market access consultancy. This combined group brings together more than 220 dedicated experts in healthcare communications globally with a focus on scientific and writing excellence, expert engagement, events management, strategic planning, and patient access consulting, for pharmaceutical and biotech companies.
Meridian HealthComms, founded in 2004, has built enduring partnerships with its pharmaceutical company and biotech clients through its strength in scientific and clinical communications, strategic planning and brand management. The acquisition enables the enhanced Group to provide its clients with extended support across integrated medical communication programmes from very early clinical development through to market access communications.
Dominic Dalli, Managing Partner, Sovereign said: ‘Bioscript has delivered superb growth in a short period of time. This is a testimony to the strength of the management team and the quality of the businesses that have joined the Group. Meridian is a well-respected and established firm and we are proud to partner the business as we continue to look for new opportunities to support strategic growth both in the UK and internationally.’
Andrew Medley, founder and CEO of Bioscript Group, said: ‘Our sector is seeing huge growth and we want to be the healthcare communications agency of choice for our clients and for our employees. Meridian joining our Group means we can continue to build our skills, capabilities services, as well as quickly widening the pool of clients we work with. Joining with other companies is part of our 5-year plan for growth.
He added: 'With Sovereign’s support, we continue to think about the exciting possibilities and places we can take the Bioscript Group and our people. We are better placed than ever to provide specialist scientific and strategic expertise that supports our clients in delivering advances in patient care.'
Dave Andrews, Managing Director of Meridian commented: 'We are delighted to be joining the Bioscript Group. Combined with greater medical communications resources, our clients now have access to a broader scope of expertise across regulatory writing, value comms and market access to allow integrated communications support throughout the product lifecycle.'